Hjem › Eggstokkreft
Kliniske studier for Eggstokkreft rekrutterer i USA
263 studier for Eggstokkreft rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
- Pittsburgh, PA30 studier
- Seattle, WA30 studier
- Atlanta, GA29 studier
- Rochester, MN29 studier
- Dallas, TX28 studier
- Oklahoma City, OK28 studier
- Queens, NY28 studier
- Durham, NC27 studier
- Portland, OR27 studier
- Detroit, MI26 studier
- Aurora, CO25 studier
- Baldwin Park, CA25 studier
- Minneapolis, MN24 studier
- San Diego, CA24 studier
- Grand Rapids, MI24 studier
- Birmingham, AL23 studier
- Washington, DC23 studier
- Miami, FL23 studier
- Orlando, FL22 studier
- Baltimore, MD22 studier
- New Haven, CT21 studier
- Tampa, FL21 studier
- Edison, NJ20 studier
- Salt Lake City, UT19 studier
- Cincinnati, OH19 studier
- Mountain View, CA19 studier
- San Francisco, CA19 studier
- Milwaukee, WI17 studier
Etter delstat
- Alabama27 studier
- Alaska7 studier
- Arizona26 studier
- Arkansas11 studier
- California105 studier
- Colorado44 studier
- Connecticut28 studier
- Delaware5 studier
- District of Columbia7 studier
- Florida81 studier
- Georgia35 studier
- Hawaii7 studier
- Idaho4 studier
- Illinois49 studier
- Indiana23 studier
- Iowa10 studier
- Kansas10 studier
- Kentucky25 studier
- Louisiana19 studier
- Maine9 studier
- Maryland40 studier
- Massachusetts67 studier
- Michigan50 studier
- Minnesota53 studier
- Mississippi6 studier
- Missouri41 studier
- Montana10 studier
- Nebraska15 studier
- Nevada11 studier
- New Hampshire4 studier
- New Jersey40 studier
- New Mexico16 studier
- New York96 studier
- North Carolina44 studier
- North Dakota7 studier
- Ohio70 studier
- Oklahoma31 studier
- Oregon34 studier
- Pennsylvania69 studier
- Rhode Island16 studier
- South Carolina17 studier
- South Dakota16 studier
- Tennessee55 studier
- Texas122 studier
- Utah29 studier
- Virginia57 studier
- Washington38 studier
- West Virginia10 studier
- Wisconsin29 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservasjonsstudie
Alder 2 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06885697A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RekruttererObservasjonsstudie
Alder 3 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01441089Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RekruttererFase 2
Alder 18 til 72 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
Alder 19 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 1. okt. 2026 · NCT07024784A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07189871TLR9 Immunotherapy for Peritoneal Carcinomatosis
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07658196Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 1. okt. 2026 · NCT07851025Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07285044A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07814248Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07360314First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06799065A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT05128825Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.